Press release
MedVi Expands Access to GLP-1 Medication - Compounded Semaglutide for Healthy Living
NEWARK, DE - MedVi Wellness, a leading telehealth provider in medical weight management, has announced the launch of its nationwide GLP-1 medication program, providing compounded semaglutide in both injectable and oral forms. Starting at $179 per month with no insurance required, MedVi [https://medvi.io] offers an affordable, physician-guided alternative to high-cost brand-name drugs such as Wegovy Registered and Ozempic Registered .
The GLP-1 medication program combines compounded semaglutide with continuous clinical oversight, 24/7 support, and fast delivery, giving patients an accessible path to sustainable weight loss backed by medical expertise.
GLP-1 Medications Driving a New Era in Weight Management
Semaglutide, a GLP-1 receptor agonist, works by reducing appetite, improving satiety, and stabilizing blood sugar levels. Clinical studies show that GLP-1 medications can help patients achieve 15-18% average weight reduction over time when combined with healthy lifestyle changes.
"GLP-1 medications like semaglutide have redefined medical weight loss," said a MedVi Wellness spokesperson. "By offering compounded semaglutide at an affordable price point with physician oversight, we are eliminating the barriers that keep most patients from accessing this transformative therapy."
Key Features of MedVi's GLP-1 Medication Program
*
Compounded Semaglutide Injections - Once-weekly dosing with pre-filled pens
*
Oral Semaglutide Tablets - A non-injectable option for daily use
*
Physician-Supervised Treatment - Personalized dosing plans from board-certified providers
*
Continuous Monitoring and Support - Unlimited check-ins and 24/7 medical access
*
Fast, Nationwide Delivery - Temperature-controlled shipping direct to patients
MedVi's program also includes GLP-1 medication for blood sugar control, benefiting patients managing type 2 diabetes while addressing weight and metabolic health together.
Addressing Drug Shortages and Rising Demand
Due to ongoing shortages of brand-name GLP-1 drugs like Wegovy Registered and Ozempic Registered , compounded semaglutide has become a vital alternative. MedVi sources exclusively from FDA-regulated, PCAB-accredited compounding pharmacies, ensuring pharmaceutical-grade standards and verified potency.
"By combining GLP-1 medication expertise with streamlined telehealth delivery, MedVi is meeting demand where traditional healthcare has fallen short," the spokesperson added. "Patients no longer need to wait months or pay thousands for care."
Why MedVi?
*
GLP-1 medications starting at $179/month
*
FDA-regulated compounding facilities and U.S.-licensed physicians
*
Transparent, no-membership pricing
*
Money-back guarantee with ongoing medical guidance
*
Service availability in all 50 U.S. states
How It Works
*
Online Medical Evaluation: Complete a secure health assessment at medvi.io [https://medvi.org/intakeform.php?uid=1&oid=5&affid=8&afid=seo&pub=5000].
*
Physician Review: A board-certified provider approves treatment if medically appropriate.
*
Medication Delivery: GLP-1 medication ships directly to the patient's home, with instructions included.
*
Ongoing Support: MedVi provides unlimited consultations, dose adjustments, and 24/7 access to licensed clinicians.
About MedVi Wellness
MedVi Wellness is a U.S.-based telehealth platform dedicated to weight loss and metabolic care through GLP-1 medications. By pairing clinical expertise with convenience and affordability, MedVi empowers patients to achieve lasting health results with doctor-led guidance and transparent pricing.
Media Contact
Company Name: MedVi Wellness
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living]
Phone: (323) 690-1564
Address:131 Continental Dr. Ste 305
City: Newark
State: DE 19713
Country: United States
Website: http://medvi.io
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MedVi Expands Access to GLP-1 Medication - Compounded Semaglutide for Healthy Living here
News-ID: 4127122 • Views: …
More Releases from ABNewswire
Canadian Author RS Wells Unveils Bold, Genre-Bending Werewolf Series with "The L …
Prince Edward Island, Canada - AUG 11th, 2025 - Author RS Wells is redefining the werewolf genre with his electrifying debut novel, The Lycanthropes Diary: Sons and Sisters [https://www.amazon.com/LYCANTHROPES-DIARY-Sons-Sisters/dp/B0DPCF49YJ]. The first installment of a thrilling new fantasy series, the book introduces a hidden world where ancient shape-shifters, known as the Sons of Lycaon, walk among us, not as cursed monsters, but as a sentient race with a complex history, powerful…
Ed Vela's 'Blood of Icarus': A Dark, Unflinching Thriller That Redefines Power a …
Award-Winning Playwright and Screenwriter's Gritty Debut Novel Set for Release on Barnes & Noble, Walmart, Apple Books, Google Books, and More
Toronto, Canada - AUG 11th, 2025 - Acclaimed playwright and screenwriter Ed Vela, known for his internationally recognized works in stage and screen, makes a compelling debut in the world of prose with his new novel, Blood of Icarus [https://www.amazon.com/Blood-Icarus-Ed-Vela/dp/B0DNBQFTVH]. A thrilling fusion of drama, suspense, and supernatural intrigue, Blood…
New Book "Last Call" by Joseph Anthony Weber Offers a Stirring Tale of Addiction …
A powerful new novel is shaking the conversation around addiction and recovery. Last Call by Joseph Anthony Weber is a raw and redemptive fictional account that doesn't just tell a story - it opens a door. Released this month, Last Call explores the darkest depths of addiction and the bright possibility of freedom, healing, and grace.
At the center of the novel is Tommy Boyle, a man broken by alcoholism, caught…
Independent Agent Richard Williams has joined Colonial Life
ORLANDO, FL - August 11, 2025 - Richard Williams has accepted the position of District General Agent (DGA) for Colonial Life's Orlando Division. He steps into this leadership role bringing over two decades of experience in the insurance and financial services industry, coupled with a proven track record in management and a forward-thinking approach to modern business solutions.
In his new capacity, Mr. Williams as an Independent Agent will be responsible…
More Releases for MedVi
MEDVi Personalized GLP-1 Medication Review - Is This the Future of Weight Loss a …
MEDVi Personalized GLP-1 Medication Review - Is This the Future of Weight Loss and Diabetes Management?
Introduction: Why Everyone's Talking About Personalized GLP-1 Medications
In today's fast-moving world of health innovation, one major trend is dominating Google searches and health forums alike-personalized GLP-1 medications. With the rise of obesity, prediabetes, and insulin resistance across all age groups, more people than ever are looking for smarter, science-backed solutions that deliver real results without…
MEDVi Revolutionizes Fitness Goals with Affordable, Doctor-Prescribed GLP-1 Medi …
Newark, Delaware - MEDVi, a leading provider of doctor-prescribed weight loss solutions, is making cutting-edge GLP-1 treatments accessible to millions across the United States. With medications like Semaglutide and Tirzepatide available for as low as $179 per month without insurance, MEDVi is transforming the weight loss industry by offering affordable, science-backed solutions.
With over 500,000 patients benefiting from its personalized programs, MEDVi provides individuals with a practical, medically supervised approach to…
